Rheumatoid arthritis (RA) affects nearly 1.5 million Americans, with almost 5% of women over 55 living with this chronic autoimmune condition. While modern treatments have improved symptom management, many patients still experience continued joint damage even during remission. Yale researchers may have discovered why.

Canadian researchers have discovered a troubling connection between air pollution and immune system changes associated with autoimmune conditions like lupus and rheumatoid arthritis.

A new perspective article from Stanford researchers proposes that dysfunction of the glymphatic system—the brain’s waste-clearance network—may be a key driver of the symptoms behind Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS). 

For this upcoming Giving Tuesday on December 2nd, please consider donating to our cause! Every donation*, big or small, makes a difference. Together, we can create a future where no one faces autoimmune disease alone.

In a new study by Stanford Medicine, researchers have found compelling evidence that EBV is a direct driver of systemic lupus erythematosus (SLE), the most common type of lupus. 

A recent study published in Nature Metabolism analyzed around 2,000 mother-offspring pairs to investigate the relationship between maternal type 1 diabetes (T1D) and the epigenetic makeup of their children.

Autoimmune research continues to discover new targets for treatments that can help patients manage their diseases. A new study by Swansea University in Wales found a protein that regulates energy production in immune cells and could be a target for new treatments.

Earlier this month, Mary E. Brunkow, Fred Ramsdell, and Dr. Shimon Sakaguchi were announced as the winners of the Nobel Prize in Medicine or Physiology for their groundbreaking discoveries on how the immune system functions and regulates itself.

ME/CFS is a difficult syndrome to diagnose. Researchers from the University of East Anglia, in collaboration with biotechnology company Oxford Biodynamics, have developed a blood test to diagnose ME/CFS.

Although some studies show that declining estrogen levels during menopause can worsen autoimmune symptoms for many women, other research examining the impact of menopause has conflicting results, and symptoms may vary from woman to woman.

New research from La Jolla Institute for Immunology (LJI) and Columbia University Irving Medical Center (CUIMC) reveals that there may be an autoimmune component to amyotrophic lateral sclerosis (ALS).